Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

NCT04685616

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Stanford University - (Stanford Cancer Institute) Stanford, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Royal North Shore Hospital Saint Leonards, New South Wales, Australia
View all 72 locations
View Trial Details
Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

NCT06140524

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Health Ann Arbor, Michigan, United States
  • NYU Langone Health Perlmutter Cancer Center New York, United States
View all 39 locations
View Trial Details
Recruiting

Hungarian National Systemic Amyloidosis Registry

NCT07689331

Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Cardiomyopathy, +24 more
Locations
  • Balatonfüredi Állami Szívkórház Balatonfüred, Hungary
  • Budapesti Szent Margit Kórház Budapest, Hungary
  • Budapesti Péterfy Sándor utcai Kórház - Rendelőintézet Budapest, Hungary
  • Department of Internal Medicine and Hematology, Semmelweis University Budapest, Hungary
View Trial Details
Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions
Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Saint-Herblain, France
  • Novartis Investigative Site Candiolo, TO, Italy
  • Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
View Trial Details
Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

NCT06960993

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Transplant, +22 more
Locations
  • Georgetown University School of Medicine Washington D.C., District of Columbia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Hackensack Meridian Health Nutley, New Jersey, United States
View Trial Details

Related conditions